Alzheimer’s Research Marked by Collaboration and Large-scale Projects, Too

Alzheimer’s Research Marked by Collaboration and Large-scale Projects, Too
A list of more than 80 compounds in clinical trials for Alzheimer’s disease, released by PhRMA, inevitably brings to mind all those that failed previously. But researchers view the new list as a source of hope, increasingly confident a breakthrough may be among them. Alzheimer’s News Today spoke to two Alzheimer's experts about expectations for these current studies. In those interviews, it became clear that — in contrast to what most people assume — collaboration plays an important role in pharmaceutical company work in this field. Academic ins
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *